Neurosurgery Unit, Department of Neurosciences, Santa Maria della Misericordia University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100, Udine, Italy.
Institute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, Rome, Italy.
Sci Rep. 2021 May 11;11(1):9964. doi: 10.1038/s41598-021-87924-2.
Surgical management of Diffuse Low-Grade Gliomas (DLGGs) has radically changed in the last 20 years. Awake surgery (AS) in combination with Direct Electrical Stimulation (DES) and real-time neuropsychological testing (RTNT) permits continuous intraoperative feedback, thus allowing to increase the extent of resection (EOR). The aim of this study was to evaluate the impact of the technological advancements and integration of multidisciplinary techniques on EOR. Two hundred and eighty-eight patients affected by DLGG were enrolled. Cases were stratified according to the surgical protocol that changed over time: 1. DES; 2. DES plus functional MRI/DTI images fused on a NeuroNavigation system; 3. Protocol 2 plus RTNT. Patients belonging to Protocol 1 had a median EOR of 83% (28-100), while those belonging to Protocol 2 and 3 had a median EOR of 88% (34-100) and 98% (50-100) respectively (p = 0.0001). New transient deficits with Protocol 1, 2 and 3 were noted in 38.96%, 34.31% and 31,08% of cases, and permanent deficits in 6.49%, 3.65% and 2.7% respectively. The average follow-up period was 6.8 years. OS was influenced by molecular class (p = 0.028), EOR (p = 0.018) and preoperative tumor growing pattern (p = 0.004). Multimodal surgical approach can provide a safer and wider removal of DLGG with potential subsequent benefits on OS. Further studies are necessary to corroborate our findings.
弥漫性低级别胶质瘤 (DLGG) 的手术治疗在过去 20 年中发生了根本性变化。在清醒手术 (AS) 中结合直接电刺激 (DES) 和实时神经心理学测试 (RTNT) 可以实现术中连续反馈,从而提高切除范围 (EOR)。本研究旨在评估技术进步和多学科技术整合对 EOR 的影响。纳入了 288 名患有 DLGG 的患者。根据手术方案将病例分层,该方案随时间而变化:1. DES;2. 融合在神经导航系统上的功能 MRI/DTI 图像的 DES;3. 方案 2 加 RTNT。属于方案 1 的患者的中位 EOR 为 83%(28-100),而属于方案 2 和 3 的患者的中位 EOR 分别为 88%(34-100)和 98%(50-100)(p=0.0001)。方案 1、2 和 3 分别有 38.96%、34.31%和 31.08%的病例出现新的短暂性缺陷,6.49%、3.65%和 2.7%的病例出现永久性缺陷。平均随访时间为 6.8 年。OS 受分子类型(p=0.028)、EOR(p=0.018)和术前肿瘤生长模式(p=0.004)的影响。多模态手术方法可以更安全、更广泛地切除 DLGG,可能对 OS 有潜在的益处。需要进一步的研究来证实我们的发现。